The role of the neurologist in the decline of stroke.

Mortality from stroke in the United States has been declining since 1900. In the population of Rochester, Minnesota the primary cause of the decline was shown to be the decrease in the incidence of new cases of stroke from 1945 through 1979. The neurologist's primary contribution to stroke prevention is the identification and management of patients who have had transient focal cerebral ischemic attacks. Although the presence of these attacks is a powerful risk for stroke occurrence, their low prevalence and the lack of clearly effective medical or surgical treatment make it unlikely that management of transient focal cerebral ischemic attacks accounts for much of the decline in the incidence or mortality of stroke.

[1]  T. Sundt,et al.  Carotid endarterectomy for unilateral carotid system transient cerebral ischemia. , 1983, Mayo Clinic proceedings.

[2]  J. Whisnant,et al.  A comparison of trends in mortality from stroke in the United States and Rochester, Minnesota. , 1982, Stroke.

[3]  W. O'Fallon,et al.  Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. , 1982, Neurology.

[4]  L. Elveback,et al.  Coronary heart disease in residents of Rochester, Minnesota. II. Mortality, incidence, and survivorship, 1950-1975. , 1981, Mayo Clinic proceedings.

[5]  Shota Fukushi,et al.  CHANGES IN SALT INTAKE AND BLOOD-PRESSURE , 1981, The Lancet.

[6]  R. Finn,et al.  BLOOD PRESSURE AND SALT INTAKE: AN INTRA-POPULATION STUDY , 1981, The Lancet.

[7]  V. Matera,et al.  RANDOMISED TRIAL OF PENTOXIFYLLINE VERSUS ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE IN PREVENTING TRANSIENT ISCHAEMIC ATTACKS , 1981, The Lancet.

[8]  M. Enjoji,et al.  Decreasing Trend in Incidence And Mortality from Stroke In Hisayama Residents, Japan , 1981, Stroke.

[9]  J. Stamler.  Aspirin in coronary heart disease , 1980 .

[10]  J. Olsson,et al.  Anticoagulant vs Anti‐Platelet Therapy As Prophylactic Against Cerebral Infarction in Transient Ischemic Attacks , 1980, Stroke.

[11]  L. Opie.  Drugs and the heart. VI. Vasodilating drugs. , 1980, Lancet.

[12]  H. Link,et al.  Prognosis in Patients With Infarction and TIA in Carotid Territory During and After Anticoagulant Therapy , 1979, Stroke.

[13]  W M O'Fallon,et al.  The declining incidence of stroke. , 1979, The New England journal of medicine.

[14]  R. Levy.  Stroke decline: implications and prospects. , 1979, The New England journal of medicine.

[15]  J. Stamler,et al.  Trends in Mortality from Cerebrovascular Diseases in the United States, 1960 to 1975 , 1978, Stroke.

[16]  F. Mcdowell,et al.  Treatment of Transient Ischemic Attacks , 1978, Stroke.

[17]  L. Elveback,et al.  Carotid and vertebral‐basilar transient ischemic attacks: Effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence— A population study , 1978, Annals of neurology.

[18]  R. Hardy,et al.  Controlled Trial of Aspirin in Cerebral Ischemia , 1977, Stroke.

[19]  Whisnant Jp,et al.  Carotid and vertebral-basilar transient cerebral ischemic attacks. A community study, Rochester, Minnesota. , 1977 .

[20]  J. Olsson,et al.  Long‐Term Anticoagulant Therapy for TIAs and Minor Strokes With Minimum Residuum , 1976, Stroke.

[21]  L. Elveback,et al.  The effect of anticoagulant therapy on the prognosis of patients with transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. , 1973, Mayo Clinic proceedings.

[22]  L. Elveback,et al.  Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. , 1973, Mayo Clinic proceedings.

[23]  L. Kurland,et al.  Natural History of Stroke in Rochester, Minnesota, 1955 Through 1969: An Extension of a Previous Study, 1945 Through 1954 , 1973, Stroke.

[24]  L. Dahl,et al.  Salt and hypertension. , 1972, The American journal of clinical nutrition.

[25]  C. Millikan.  Reassessment of Anticoagulant Therapy in Various Types of Occlusive Cerebrovascular Disease , 1971 .

[26]  W. S. Wilson,et al.  Transient ischemic attacks in a community. , 1969, JAMA.

[27]  R. Paffenbarger,et al.  Trends in cerebrovascular disease mortality based on multiple cause tabulation of death certificates 1930-1960. A comparison of trends in Memphis and Baltimore. , 1968, American journal of epidemiology.

[28]  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. , 1967, JAMA.

[29]  R. N. Baker,et al.  Transient ischemic strokes , 1966, Neurology.

[30]  F. R. Zadik.  FRACTURE OF THE FEMORAL NECK. , 1964, Lancet.

[31]  Surgical and anticoagulant therapy of occlusive cerebrovascular disease. , 1963, Annals of internal medicine.

[32]  C. Fisher.  Anticoagulant therapy in cerebral thrombosis and cerebral embolism , 1961, Neurology.

[33]  W. Miall.  Follow-up Study of Arterial Pressure in the Population of a Welsh Mining Valley , 1959, British medical journal.